Psychological Studies
psychological studies
Ebselen: a lithium-mimetic without lithium side-effects?
Development of new medications for mental health conditions is a pressing need given the high proportion of people not responding to available treatments. We hope that presenting ebselen to a wider audience will inspire further studies on this promising agent with a benign side-effects profile. Laboratory research, animal research and human studies suggest that ebselen shares many features with the mood stabilising drug lithium, creating a promise of a drug that would have a similar clinical effect but without lithium’s troublesome side-effect profile and toxicity. Both drugs have a common biological target, inositol monophosphatase, whose inhibition is thought key to lithium’s therapeutic effect. Both drugs have neuroprotective action and reduce oxidative stress. In animal studies, ebselen affected neurotransmitters involved in the development of mental health symptoms, and in particular, produced effects of serotonin function very similar to lithium. Both ebselen and lithium share behavioural effects: antidepressant-like effects in rodent models of depression and decrease in behavioural impulsivity, a property associated with lithium's anti-suicidal action. Human neuropsychological studies support an antidepressant profile for ebselen based on its positive impact on emotional processing and reward seeking. Our group currently is exploring ebselen’s effects in patients with mood disorders. A completed ‘add-on’ clinical trial in mania showed ebselen’s superiority over placebo after three weeks of treatment. Our ongoing experimental research explores ebselen’s antidepressant profile in patients with treatment resistant depression. If successful, this will lead to a clinical trial of ebselen as an antidepressant augmentation agent, similar to lithium.
The contribution of the dorsal visual pathway to perception and action
The human visual system enables us to recognize objects (e.g., this is a cup) and act upon them (e.g., grasp the cup) with astonishing ease and accuracy. For decades, it was widely accepted that these different functions rely on two separated cortical pathways. The ventral occipitotemporal pathway subserves object recognition, while the dorsal occipitoparietal pathway promotes visually guided actions. In my talk, I will discuss recent evidence from a series of neuropsychological, developmental and neuroimaging studies that were aimed to explore the nature of object representations in the dorsal pathway. The results from these studies highlight the plausible role of the dorsal pathway in object perception and reveal an interplay between shape representations derived by the two pathways. Together, these findings challenge the binary distinction between the two pathways and are consistent with the view that object recognition is not the sole product of ventral pathway computations, but instead relies on a distributed network of regions.
The recent history of the replication crisis in psychology & how Open Science can be part of the solution
In recent years, more and more evidence has accumulated showing that many studies in psychological research cannot be replicated, effects are often overestimated, and little is publicly known about unsuccessful studies. What are the mechanisms behind this crisis? In this talk, I will explain how we got there and why it is still difficult to break free from the current system. I will further explain which role Open Science plays within the replication crisis and how it can help to improve science. This might sound like a pessimistic, negative talk, but I will end it on a positive note, I promise!